title: Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM).
abstract: An effective immune response requires a prompt but measured action against the pathological insult, to prevent over-zealous inflammatory-mediated tissue destruction. In cancer, defective or incompetent immune responses may paradoxically result in disease progression despite an immune attempt at elimination. Tumour-induced immunosuppression may not only result from soluble factors and altered antigenicity, but also from cellular-mediated tumour-induced immune evasion. Multiple myeloma (MM) is associated with both cellular and humoral immune deficiencies and increased T(Reg) cells. In vitro modelling has indicated that the tumour cells directly induce functional T(Reg) cells. In light of this recent evidence, it now seems that the most promising and synergistic approaches for cancer immunotherapy would involve specific anti-tumour immunity and simultaneous reduction of tumour-induced immune-regulation. This review sets out the basic understanding of the human immune response, its dysregulation in cancer and proposes how this knowledge may influence future treatment strategies to maximise the anti-tumour immune response.
authors.affiliation: Transplant Immunology Group, Academic Department of Haematology & Oncology, University of Leeds, UK.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Feyler
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Selby
authors.forename: Gordon
authors.initials: G
authors.lastname: Cook
mesh_terms: D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods; D009101:Multiple Myeloma / Q000276:immunology* / Q000628:therapy*; D012106:Research / Q000639:trends